An approach to rule-out an acute cardiovascular event or death in emergency department patients using outcome-based cutoffs for high-sensitivity cardiac troponin assays and glucose

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 282-287

  Shortt, Colleen ^a   Phan, Kim ^b   Hill, Stephen A ^a   Worster, Andrew ^a   Kavsak, Peter A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Acute coronary syndrome; Emergency department; Glucose; Health outcomes; High sensitivity cardiac troponin; Rule out

Indexed keywords

GLUCOSE; HIGH SENSITIVITY CARDIAC TROPONIN; TROPONIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEART INFARCTION; HUMAN; IMMUNOASSAY ANALYZER; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; THORAX PAIN; ACUTE CORONARY SYNDROME; ACUTE DISEASE; BIOASSAY; BLOOD; CARDIOVASCULAR DISEASES; CHEST PAIN; EMERGENCY HEALTH SERVICE; METABOLISM; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROCEDURES; STANDARDS; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; BIOMARKERS; CARDIOVASCULAR DISEASES; CHEST PAIN; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TROPONIN I;

EID: 84924627591     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.11.010     Document Type: Article

References (36)

1. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
2. deFilippi C.R., de Lemos J.A., Christenson R.H., Gottdiener J.S., Kop W.J., Zhan M., et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010, 304:2494-2502.
3. Saunders J.T., Nambi V., de Lemos J.A., Chambless L.E., Virani S.S., Boerwinkle E., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011, 123:1367-1376.
4. Kavsak P.A., Xu L., Yusuf S., McQueen M.J. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem 2011, 57:1146-1153.
5. McQueen M.J., Kavsak P.A., Xu L., Shestakovska O., Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem 2013, 46(1-2):5-9.
6. Omland T., Pfeffer M.A., Solomon S.D., de Lemos J.A., Røsjø H., Šaltyte˙ Benth J., et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013, 61:1240-1249.
7. Zeller T., Tunstall-Pedoe H., Saarela O., Ojeda F., Schnabel R.B., Tuovinen T., et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014, 35:271-281.
8. McKie P.M., AbouEzzeddine O.F., Scott C.G., Mehta R., Rodeheffer R.J., Redfield M.M., et al. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic peptide predict heart failure and mortality in the general population. Clin Chem 2014, 60:1225-1233.
9. Body R., Carley S., McDowell G., Jaffe AS., France M., Cruickshank K., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. Am Coll Cardiol 2011, 58:1332-1339.
10. Cullen L., Mueller C., Parsonage W.A., Wildi K., Greenslade J.H., Twerenbold R., et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013, 62:1242-1249.
11. Bandstein N., Ljung R., Johansson M., Holzmann M.J. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014, 63:2569-2578.
12. Kavsak P.A., Wang X., Ko D.T., MacRae A.R., Jaffe A.S. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009, 55:1809-1815.
13. Kavsak P.A., Worster A. Dichotomizing high-sensitivity cardiac troponin T results and important analytical considerations. J Am Coll Cardiol 2012, 59:1570.
14. Kavsak P.A. Quality control material testing and the importance of "treating it like a patient's sample". Clin Biochem 2014, 47:147-149.
15. Kavsak P.A., Hill S.A., McQueen M.J., Devereaux P.J. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013, 59(3):574-576.
16. de Mulder M., Umans V.A., Cornel J.H., van der Zant F.M., Stam F., Oemrawsingh R.M., et al. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med 2013, 173:1896-1904.
17. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl. 1):62-69.
18. Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999, 34:146-154.
19. Timmer J.R., Ottervanger J.P., de Boer M.J., Dambrink J.H., Hoorntje J.C., Gosselink A.T., et al. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005, 45:999-1002.
20. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008, 117:1610-1619.
21. Lippi G., Cervellin G., Targher G. Random plasma glucose measurement may improve the diagnostic specificity of highly sensitive troponin in the emergency department. Int J Cardiol 2012, 155:172-173.
22. Kavsak P.A., Hill S.A., Bhanich Supapol W., Devereaux P.J., Worster A. Biomarkers for predicting serious cardiac outcomes at 72hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem 2012, 58:298-302.
23. Kavsak P.A., Worster A., You J.J., Oremus M., Shortt C., Phan K., et al. Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome. Clin Chem 2013, 59:1407-1410.
24. Kavsak P.A., Shortt C., Pond G., Worster A. High-sensitivity cardiac troponin I for predicting death in a female emergency department population. Clin Chem 2014, 60:271-273.
25. Kavsak P.A., MacRae A.R., Yerna M.J., Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009, 55:573-577.
26. Mansour M., Clark L., Kavsak P.A. Effect of freeze-thaw and refrigeration conditions on high-sensitivity troponin T concentrations. Ann Clin Biochem 2012, 49:101-102.
27. Rezvanpour A., Shortt C., Clark L., Worster A., Kavsak P.A. Analytical factors to consider when assessing a high-sensitivity cardiac troponin I assay compared to a contemporary assay in clinical studies. Clin Chim Acta 2014, 429:6-7.
28. Worster A., Devereaux P.J., Heels-Ansdell D., Guyatt G.H., Opie J., Mookadam F., et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005, 172:1685-1690.
29. Smith S.C., Benjamin E.J., Bonow R.O., Braun L.T., Creager M.A., Franklin B.A., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011, 124:2458-2473.
30. Apple F.S., Ler R., Murakami M.M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012, 58:1574-1581.
31. Keller T., Zeller T., Ojeda F., Tzikas S., Lillpopp L., Sinning C., et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011, 306:2684-2693.
32. Kavsak P.A., Rezvanpour A., Chen Y., Adeli K. Assessment of the 99th or 97.5th percentile for cardiac troponin I in a healthy pediatric cohort. Clin Chem 2014, 60:1574-1575.
33. Shortt C.R., Worster A., Hill S.A., Kavsak P.A. Comparison of hs-cTnI, hs-cTnT, hFABP and GPBB for identifying early adverse cardiac events in patients presenting within six hours of chest pain-onset. Clin Chim Acta Apr 18 2013, 419:39-41.
34. Selvin E., Lazo M., Chen Y., Shen L., Rubin J., McEvoy J.W., et al. Diabetes, pre-diabetes and incidence of subclinical myocardial damage. Circulation 2014, 130:1374-1382.
35. Apple F.S., Jaffe A.S., Collinson P., Mockel M., Ordonez-Llanos J., Lindahl B., et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015, 48:201-203.
36. Kavsak P.A., Jaffe A.S., Hickman P.E., Mills N.L., Humphries K.H., McRae A., et al. Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. Clin Biochem 2014, 47:155-157.